Sleep apnea guide

Zepbound for sleep apnea: FDA approval, results, dose and insurance coverage

Zepbound® (tirzepatide) is the first drug the FDA has approved to treat obstructive sleep apnea (OSA). The approval, dated December 20, 2024, covers adults who have obesity and moderate to severe OSA.1 In two year-long trials it removed 25 to 29 breathing interruptions per hour of sleep, compared with about 5 on placebo.2

Get Started

Key points

  • Trial results: over 52 weeks on 10 mg or 15 mg, breathing events fell 51% to 59% and body weight about 18% to 20%. Placebo: about 3% and 2%.
  • Dose: 10 mg or 15 mg weekly, reached in steps from 2.5 mg.
  • CPAP: keep using it. The trials did not test when PAP therapy can stop.
  • Diagnosis first: a sleep study is what confirms moderate to severe OSA.

Is Zepbound FDA-approved for sleep apnea?

Yes. Since December 20, 2024, Zepbound has been FDA-approved for adults who have obesity and moderate to severe obstructive sleep apnea. The FDA called it the first drug treatment option for certain people with OSA, to be used with a lower-calorie diet and more physical activity.1

What the approval covers and leaves out

  • Obstructive sleep apnea only. In OSA the upper airway is blocked many times during sleep. Central sleep apnea, where the brain fails to send the signals to breathe, is a different condition,3 and the label does not mention it.2
  • Moderate to severe disease. In the approval trials that meant an apnea-hypopnea index (AHI) of 15 or more events an hour.2
  • Obesity. The trials defined it as a body mass index of 30 or higher.2 Our BMI calculator shows yours.

Mounjaro® is also tirzepatide, but its label covers type 2 diabetes and has no sleep apnea indication.4 Compounded tirzepatide is not FDA-approved for any use, sleep apnea included, and the FDA does not review compounded drugs for safety, effectiveness or quality.5

Does Zepbound help sleep apnea, and how?

Yes, mostly by lowering body weight. The FDA said the drop in breathing events seen in the trials is likely related to the weight participants lost.1 Obesity is one of the factors that can narrow the airway.3

Tirzepatide activates the GIP and GLP-1 receptors. People taking it eat fewer calories, and the stomach empties more slowly.2 Weight comes down over months, and breathing during sleep improves with it.

What Zepbound does not do. It does not hold your airway open on the night you inject it. A CPAP machine does that with constant air pressure.6

Zepbound sleep apnea results: the SURMOUNT-OSA trials

The evidence is SURMOUNT-OSA: two 52-week, double-blind trials, funded by Eli Lilly, that enrolled 469 adults who had obesity and moderate to severe OSA but not type 2 diabetes.7 Study 1 enrolled people unable or unwilling to use PAP therapy. Study 2 enrolled people already on PAP.2

Each week, participants injected placebo or Zepbound (10 mg or 15 mg). The yardstick was AHI, the number of apneas and hypopneas in an hour of sleep. It averaged 51.5 at the start of Study 1 and 49.5 in Study 2.7

Measure at week 52Study 1: Zepboundnot using PAPStudy 1: placebonot using PAPStudy 2: Zepboundusing PAPStudy 2: placebousing PAP
Change in AHI, events per hour−25.3−5.3−29.3−5.5
Change in AHI, percent−50.7%−3.0%−58.7%−2.5%
People whose AHI fell 50% or more61.2%19%72.4%23.3%
Remission, or mild OSA without symptoms42.2%15.9%50.2%14.3%
Change in body weight−17.7%−1.6%−19.6%−2.3%

Sources: Zepbound label and SURMOUNT-OSA report.2,7 Remission is an AHI under 5. Mild OSA without symptoms is an AHI of 5 to 14 with an Epworth Sleepiness Scale score of 10 or less. Individual results vary.

What the numbers mean

Against placebo, Zepbound removed about 20 more breathing events an hour in Study 1 and about 24 more in Study 2.7 Subtracting the average drop from a starting point near 50 still leaves roughly 26 events an hour in Study 1 and 20 in Study 2. The label counts 15 to under 30 as moderate sleep apnea.2

Between 42% and 50% of people on Zepbound finished the year in remission or with mild, symptom-free OSA. Half or more did not. Systolic blood pressure and hypoxic burden, a low-oxygen measure, also improved more with Zepbound.2 These results belong to Lilly’s Zepbound, not to compounded tirzepatide, and they do not predict your own.

Who can get Zepbound for sleep apnea?

The FDA-approved use fits adults who have both obesity and moderate to severe OSA.2 A prescriber looks for three things:

  • A sleep study report that puts your OSA in the moderate to severe range (an AHI of 15 or more in the trials).
  • A BMI of 30 or higher, the trials’ definition of obesity.
  • No contraindication. Zepbound is not for anyone who has had medullary thyroid carcinoma or has a family member who has, anyone with Multiple Endocrine Neoplasia syndrome type 2, or anyone with a serious allergy to tirzepatide.2

If you suspect sleep apnea but have no diagnosis

Snoring, gasping for air during sleep and heavy daytime sleepiness are reasons to ask a healthcare provider about sleep apnea, which is diagnosed with a sleep study.3 Ask for a copy of the report, including your AHI.

When your OSA is mild, or your BMI is below 30

The sleep apnea indication does not apply, but Zepbound’s weight management indication might. It covers adults with obesity, or with overweight plus a weight-related condition, and the label’s weight trials counted OSA as one such condition.2

How to start with Zealthy

Zealthy providers are U.S.-licensed physicians and nurse practitioners who prescribe Zepbound to eligible adults in all 50 states when they find it appropriate.

  1. Bring your diagnosis. An OSA diagnosis comes from a sleep study ordered by a clinician. Have that report ready.
  2. Complete the online intake. A licensed provider reviews it. No live appointment is required to start.
  3. Leave the paperwork to us. Zealthy’s coordination team submits the prior authorization for brand-name Zepbound. Your plan decides, and approval is never guaranteed.
  4. Fill and follow up. The prescription goes to your own pharmacy. Keep seeing your sleep clinician.

Get Started

Zepbound OSA dose: 10 mg or 15 mg weekly

For obstructive sleep apnea, the label recommends a weekly maintenance dose of 10 mg or 15 mg, injected under the skin. Treatment begins at 2.5 mg and rises in 2.5 mg steps, with at least 4 weeks at each step, to limit stomach side effects.2

WeeksWeekly doseRole
1 to 42.5 mgStarting dose, not for maintenance
5 to 85 mgRequired second step
9 to 127.5 mgStep up
13 to 1610 mgEarliest OSA maintenance dose
17 to 2012.5 mgOptional step up
21 onward15 mgMaximum dose

The quickest timetable the label permits.2 Your provider can hold any step longer.

For weight reduction, 5 mg also counts as a maintenance dose. For sleep apnea, only 10 mg and 15 mg do.2

Injection day and missed doses

Inject once a week, at any hour, with or without meals, in the abdomen or thigh. If you miss a dose, take it within 4 days. After that, skip it and wait for your next regular day.2

Zepbound and CPAP: do you still need your machine?

Yes, until a sleep clinician retests you and says otherwise. Zepbound’s label states that its trials did not evaluate the timing or appropriateness of stopping PAP therapy.2

QuestionZepboundCPAP and other PAP machines
How it treats OSALowers body weight, which the FDA links to fewer breathing events1Air pressure through the nose or mouth keeps the airway open6
When it helpsGradually, over monthsDuring sleep, on nights you use it
Common problemsNausea, diarrhea, vomiting, constipation2Congestion, dry eyes or mouth, nosebleeds, runny nose6

What Study 2 tells PAP users

Everyone in Study 2 was already on PAP. With Zepbound added, 50.2% reached remission or mild, symptom-free OSA, against 14.3% on placebo. Participants were told to pause PAP for 7 days before the final sleep study, so that test recorded their breathing without the machine.2

That makes retesting a fair question once your weight has come down. It does not show that your own airway stays open without PAP, and sleep apnea left untreated increases the risk of stroke and heart attack.3

If you cannot tolerate CPAP

Study 1 enrolled only people who could not or would not use PAP, and on Zepbound their AHI fell by about half.2 If that is you, raise Zepbound with your doctor, along with the custom-fitted oral devices that the National Heart, Lung, and Blood Institute (NHLBI) describes.6

Zepbound sleep apnea insurance coverage and cost

What you pay comes down to your plan, and to whether it covers Zepbound for sleep apnea, an FDA-approved use separate from weight loss.

Commercial insurance

Coverage is decided plan by plan, so ask about Zepbound for obstructive sleep apnea by name and expect a prior authorization. Zealthy’s coordination team submits it for brand-name Zepbound. When your plan covers it, your copay can be as low as $25 a month. An active Zealthy membership is required, and approval is never promised.

With commercial coverage, Lilly’s Zepbound Savings Card can lower a fill of the single-dose pen to as little as $25, with savings capped at $100 per one-month fill. It expires December 31, 2026 (terms as of November 2026).8 See our GLP-1 insurance checker.

Does Medicare cover Zepbound for obstructive sleep apnea?

It may, depending on your Part D plan. Part D can cover a GLP-1 medication only for an FDA-approved use other than obesity, and KFF names sleep apnea as one.9 Medicare.gov says only that a plan “might cover” it,10 and we found no CMS statement that every plan does. Check your plan’s drug list.

  • The Medicare GLP-1 Bridge does not apply. Its $50 monthly copay is for weight management, and people whose sleep apnea is moderate to severe are not eligible.10
  • Savings cards cannot be used by anyone enrolled in Medicare, Medicaid, TRICARE, VA or another government program.8

For Medicaid, KFF reports that state programs must cover Zepbound for its sleep apnea indication, usually with prior authorization.11

Zepbound cost without insurance

Lilly’s self-pay price for the KwikPen or single-dose vials is $299 a month at 2.5 mg, $399 at 5 mg, and $449 at 7.5 mg and above, as of November 2026. The $449 price holds only when you refill within 45 days. Otherwise 10 mg and 15 mg, the sleep apnea doses, cost $699.12 These offers run through December 31, 2026.8

What Zealthy costs

Membership costs $39 the first month and $135 a month after that. Medication is separate. Our Zepbound cost breakdown has every price.

Zealthy providers can also prescribe compounded tirzepatide when appropriate, but it is not a route to the sleep apnea approval. It is not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness or quality.5 See our tirzepatide page.

Zepbound side effects for sleep apnea patients

The label says adverse reactions in the OSA trials were similar to those in the weight management trials,2 and the trial report calls the most frequent ones gastrointestinal and mostly mild to moderate.7

In the larger weight trials, nausea was reported by 25% to 29% of those taking Zepbound (8% on placebo), diarrhea by 19% to 23% (8%), constipation by 11% to 17% (5%) and vomiting by 8% to 13% (2%). Most nausea, vomiting and diarrhea came while the dose was rising.2

Two points specific to sleep apnea

  • Stomach symptoms on PAP. NHLBI lists stomach discomfort and bloating as PAP side effects to report to your provider.6 Zepbound can cause them too,2 so tell both clinicians.
  • Surgery and sedation. Zepbound slows stomach emptying, and food or liquid has rarely entered the lungs during anesthesia in people on this type of medicine. Tell every surgical team you take it.2

Serious risks are in the important safety information. See also Zepbound side effects and our GLP-1 side effects guide.

Zepbound and sleep apnea: common questions

When did the FDA approve Zepbound for sleep apnea?

On December 20, 2024. The approval covers adults who have obesity and moderate to severe obstructive sleep apnea, alongside a lower-calorie diet and more physical activity. It does not extend to central sleep apnea, to children, or to other tirzepatide products such as Mounjaro.

Can Zepbound replace my CPAP machine?

Not unless your sleep clinician retests you and agrees. Zepbound’s trials did not study when PAP can be stopped, and half or more of participants still had sleep apnea short of remission after a year. Zepbound works slowly, while CPAP works every night you use it.

What is the Zepbound OSA dose?

For obstructive sleep apnea, the weekly maintenance dose is 10 mg or 15 mg. Treatment starts at 2.5 mg for 4 weeks, moves to 5 mg, then rises 2.5 mg at a time, at least 4 weeks apart. At the quickest, 10 mg arrives in week 13.

How soon does Zepbound start improving sleep apnea?

Expect change over months, not days. The trials measured results at 52 weeks, after up to 20 weeks of dose increases, and the FDA ties the improvement to weight loss, which is gradual. Your sleep clinician decides when a repeat sleep study makes sense.

Will my insurance pay for Zepbound if I have sleep apnea?

It depends on your plan. Ask about Zepbound for obstructive sleep apnea by name, and expect a prior authorization, which Zealthy’s coordination team submits for brand-name Zepbound. When your plan covers it, the copay can be as low as $25 a month. Approval is never guaranteed.

Does Medicare cover Zepbound for obstructive sleep apnea?

It may. A Part D plan can cover a GLP-1 medication for an FDA-approved use other than obesity, and sleep apnea is one, but each plan sets its own drug list. The $50 Medicare GLP-1 Bridge excludes people with moderate to severe sleep apnea.

Do I need a sleep study before starting Zepbound for sleep apnea?

Yes, for the sleep apnea indication. The approval is for moderate to severe OSA, and a sleep study ordered by a clinician is how that diagnosis is made. Bring the report to your Zealthy intake so your provider can see your diagnosis and your AHI.

Do Mounjaro, Wegovy or Ozempic have a sleep apnea approval?

No. Of the four brands, only Zepbound carries an FDA-approved use for obstructive sleep apnea. Mounjaro shares its ingredient, tirzepatide, yet its label is for type 2 diabetes. Wegovy and Ozempic are semaglutide, and sleep apnea is not among the uses on either label.

Is compounded tirzepatide approved for sleep apnea?

No. Compounded tirzepatide is not FDA-approved for sleep apnea or any other condition, and the FDA does not review compounded drugs for safety, effectiveness or quality. The SURMOUNT-OSA results come from Lilly’s Zepbound and cannot be applied to a compounded product.

Important safety information for Zepbound

A summary of the Zepbound prescribing information and Medication Guide.2,13 It does not replace either one.

Boxed warning: risk of thyroid C-cell tumors

Tirzepatide caused thyroid C-cell tumors in rats. It is not known whether Zepbound causes them, including medullary thyroid carcinoma (MTC), in people. Do not use Zepbound if you or a family member has had MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Report a neck lump, lasting hoarseness, trouble swallowing or shortness of breath.

Do not use Zepbound if

  • You or a family member has had MTC, or you have MEN 2.
  • You have had a serious allergic reaction to tirzepatide or any ingredient in Zepbound.

Tell your provider if you

  • Have had pancreas problems, severe stomach problems such as gastroparesis, or diabetic retinopathy.
  • Have surgery or a procedure with anesthesia or deep sedation planned.
  • Are pregnant, plan to be, or are breastfeeding. Zepbound may harm an unborn baby.
  • Take insulin or a sulfonylurea, or use birth control pills, which may work less well for 4 weeks after you start and after each dose increase.

Serious side effects

Severe stomach problems, kidney problems from dehydration, gallbladder problems, pancreatitis, serious allergic reactions, low blood sugar, vision changes in people with type 2 diabetes, and food or liquid entering the lungs during anesthesia. Stop Zepbound and get medical help right away for severe stomach pain that will not go away, or for swelling of the face, lips, tongue or throat or trouble breathing.

On November 9, 2026, the FDA said all GLP-1 medications, including Zepbound, must add a warning about a possible increased risk of NAION, a rare cause of sudden vision loss in one eye. Seek care right away for sudden vision changes.14

Most common side effects

Nausea, diarrhea, vomiting, constipation, stomach pain, indigestion, injection site reactions, fatigue, allergic reactions, burping, hair loss and heartburn. Report side effects to the FDA at 1-800-FDA-1088.

Sources

  1. FDA. FDA approves first medication for obstructive sleep apnea. December 20, 2024. https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea
  2. Zepbound (tirzepatide) Prescribing Information. Eli Lilly and Company. Revised August 2026. https://pi.lilly.com/us/zepbound-uspi.pdf
  3. National Heart, Lung, and Blood Institute. What is sleep apnea? https://www.nhlbi.nih.gov/health/sleep-apnea
  4. Mounjaro (tirzepatide) Prescribing Information. Eli Lilly and Company. Revised August 2026. https://pi.lilly.com/us/mounjaro-uspi.pdf
  5. FDA. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  6. NHLBI. Sleep apnea treatment. https://www.nhlbi.nih.gov/health/sleep-apnea/treatment
  7. Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the treatment of obstructive sleep apnea and obesity. N Engl J Med. 2024;391(13):1193-1205. https://pubmed.ncbi.nlm.nih.gov/38912654/
  8. Eli Lilly and Company. Zepbound savings options and Savings Card terms. Accessed November 18, 2026. https://zepbound.lilly.com/savings
  9. KFF. What to know about the BALANCE Model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge. Updated May 11, 2026. https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/
  10. Medicare.gov. Weight loss drugs (Medicare GLP-1 Bridge). https://www.medicare.gov/glp1bridge
  11. KFF. Medicaid coverage of and spending on GLP-1s. 2026. https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/
  12. Eli Lilly and Company. Zepbound through LillyDirect. Accessed November 18, 2026. https://www.lilly.com/lillydirect/zepbound
  13. Zepbound (tirzepatide) Medication Guide. Eli Lilly and Company. Revised August 2026. https://pi.lilly.com/us/zepbound-us-mg.pdf
  14. FDA. FDA requires safety labeling changes for GLP-1 receptor agonists due to potential increased risk of rare but serious eye condition. November 9, 2026. https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential

Have a sleep apnea diagnosis? See if Zepbound is an option

Answer a few health questions online. A licensed provider reviews them, and membership starts at $39 for the first month.

Get Started
A Zealthy provider shown on a phone screen
Your care team

Zepbound care that works alongside your sleep clinician

A licensed Zealthy provider reviews your health history and your sleep apnea diagnosis before prescribing, and our coordination team handles the prior authorization paperwork. Your sleep clinician keeps managing your PAP therapy and follow-up sleep testing.

50 statesLicensed providers for members in every state
No appointment neededYour intake is reviewed online, and questions are handled by message
7 days a weekSupport Monday to Friday 9am to 6pm ET, weekends 12pm to 6pm ET

The medical information on this page is reviewed by the Zealthy care team against FDA prescribing information and published clinical trials. It is general education, not personal medical advice.

Zealthy members

What Zealthy members say

One of the things I appreciate most about semaglutide is its convenience. The once-weekly dosing schedule has made it incredibly easy to integrate into my routine. It's a relief to know that I don't have to worry about multiple daily injections or complicated medication schedules.
Michelle, 33 | Lost 48 pounds
I started semaglutide at the recommendation of my Zealthy provider and I'm so happy with that decision. I signed up for their weight loss program and they've been giving me everything I need to make better lifestyle choices to get results that last. And the program's super affordable. 10/10 I can't recommend this enough.
Michael, 37 | Lost 29 pounds
Getting support a weight loss program has always been hard for me. I had been wanting to start one with a medication component for a while and Zealthy was the first one that made it easy for me with weight loss shots sent to me. They made it SO affordable and the medical team is great.
Susanne, 60 | Lost 33 pounds
Since I started, I have already lost 35 pounds and feel so much better. My doctor also helped me get a prescription for ozempic and he is always available to answer my questions in the message portal. This made me feel a lot more comfortable and excited to lose weight.
Rachel | Zealthy Member
The weight loss program is fantastic. Everyone has been so helpful and has helped me feel much more excited about the process. I was nervous to see my weight loss treatment plan, since I have done programs in the past, but they always wanted me to make drastic changes. I mentioned all of this to my weight loss coach and she was very understanding and made a customized plan for me.
John | Zealthy Member
I've been a member for 6 months now and have received all my medication every 3 months. Everyone has been so helpful and my care team is always available to help me!
Sara | Zealthy Member

Individual results may vary. These are the experiences of Zealthy members and are not a guarantee of any outcome. Medication is prescribed only when a licensed provider finds it appropriate.

Medications

GLP-1 medications Zealthy providers can prescribe

Brand-name or compounded, a licensed provider decides what fits your health history. Our insurance team handles the prior authorization paperwork for brand-name medication.

Compounded medications are prepared by a partner pharmacy for an individual prescription. They are not FDA-approved, which means the FDA has not reviewed them for safety, effectiveness or quality. Zealthy membership ($39 for the first month, then $135 a month) is billed separately from medication. A prescription is written only if a licensed provider finds it appropriate.